| Literature DB >> 33916994 |
Raffaela S Berger1, Christian J Wachsmuth1, Magdalena C Waldhier1, Kathrin Renner-Sattler2, Simone Thomas2,3, Anuhar Chaturvedi4, Hans-Helmut Niller5, Elisabeth Bumes6, Peter Hau6, Martin Proescholdt7, Wolfram Gronwald1, Michael Heuser4, Marina Kreutz2, Peter J Oefner1, Katja Dettmer1.
Abstract
In recent years, onco-metabolites like D-2-hydroxyglutarate, which is produced in isocitrate dehydrogenase-mutated tumors, have gained increasing interest. Here, we report a metabolite in human specimens that is closely related to 2-hydroxyglutarate: the intramolecular ester of 2-hydroxyglutarate, 2-hydroxyglutarate-γ-lactone. Using 13C5-L-glutamine tracer analysis, we showed that 2-hydroxyglutarate is the endogenous precursor of 2-hydroxyglutarate-lactone and that there is a high exchange between these two metabolites. Lactone formation does not depend on mutated isocitrate dehydrogenase, but its formation is most probably linked to transport processes across the cell membrane and favored at low environmental pH. Furthermore, human macrophages showed not only striking differences in uptake of 2-hydroxyglutarate and its lactone but also in the enantiospecific hydrolysis of the latter. Consequently, 2-hydroxyglutarate-lactone may play a critical role in the modulation of the tumor microenvironment.Entities:
Keywords: D-2-hydroxyglutarate; IDH1/2 mutation; acute myeloid leukemia; lactonization
Year: 2021 PMID: 33916994 DOI: 10.3390/cancers13081756
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639